Evidence map›Paper›PMID 26472020›Full record

ArticleOncotarget2015

Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells.

Yugang Liu, Wenan Qiang, Xiaofei Xu, Ruifen Dong, Alison M Karst, Zhaojian Liu, Beihua Kong, Ronny I Drapkin, Jian-Jun Wei

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. MicroRNA and ROS Crosstalk in Cardiac and Pulmonary Diseases.International journal of molecular sciences · 2020
    Review
  11. Review
  12. Review
  13. MicroRNA Networks Modulate Oxidative Stress in Cancer.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. A step-by-step microRNA guide to cancer development and metastasis.Cellular oncology (Dordrecht, Netherlands) · 2017
    Review
  18. MicroRNA Regulation of Oxidative Stress-Induced Cellular Senescence.Oxidative medicine and cellular longevity · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yugang LiuDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Wenan QiangDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Xiaofei XuDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Ruifen DongDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Alison M KarstThe Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Zhaojian LiuDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Beihua KongDepartment of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Ronny I DrapkinThe Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Jian-Jun WeiDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Northwestern University · USHarvard University · USQilu Hospital of Shandong University · CN

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Daniela E Matei · 1993 to 2026
$153.9M
MiR-182 overexpression in early tumorigenesis of high grade serous carcinomaR21CA167038 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WEI, JIAN-JUN · 2013 to 2014
$365k
NCI NIH HHS P30 CA060553NCI NIH HHS R21 CA167038
6 · The paper itself

Abstract

High grade serous ovarian carcinoma (HGSC) is a DNA instable tumor and its precursor is commonly found originating from the fimbriated end of the fallopian tube secretory epithelial (FTSE) cells. The local stresses via ovulation and related inflammation are risks for HGSC. In this study, we examined the cellular and molecular responses of FTSE cells to stress. We found that excess intracellular reactive oxygen species (ROS) in normal FTSE cells upregulated a subset of microRNA expression (defined as ROSmiRs). Most ROSmiRs' expression and function were influenced and regulated by p53, and together they drove the cells into stress-induced premature senescence (SIPS). However, ROS-induced miR-182 is regulated by β-catenin, not by p53. In normal FTSE cells, miR-182 overexpression triggers cellular senescence by p53-mediated upregulation of p21. Conversely, in cells with p53 mutations, miR-182 overexpression no longer enhances p21 but functions as an "Onco-miR". p53 dysfunction is a prerequisite for miR-182-mediated tumorigenesis. In addition, we found that human follicular fluid could significantly induce intracellular ROS in normal FTSE cells. These findings suggest that ROS and p53 mutations may trigger a series of events, beginning with overexpressing miR-182 by ROS and β-catenin, impairing the DNA damage response, promoting DNA instability, bypassing senescence and eventually leading to DNA instable tumors in FTSE cells.

Indexed as

AnimalsCarcinogenesisCell DifferentiationCell ProliferationCellular SenescenceEpithelial CellsFallopian TubesFemaleHeterograftsHumansMiceMice, NudeMicroRNAsOxidative StressReactive Oxygen SpeciesTumor Suppressor Protein p53MicroRNAsMirn182 microRNA, humanReactive Oxygen SpeciesTumor Suppressor Protein p53fallopian tube secretory cellsp53ROS-induced miRNA (ROSmiR)senescence bypasstumorigenesis

Identifiers

PMID26472020
PMCPMC4770751
OpenAlexW2179521524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.